跳至主要内容
临床试验/NCT05903521
NCT05903521终止不适用

Long-term Impact of Surgically Induced Rapid Weight Loss on Telomere Length and Its Potential Implications in the Genesis and Prevention of Neoplastic Disease Processes in Subjects With Severe Obesity

The Cleveland Clinic1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年6月12日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
120
试验地点
1
主要终点
Telomere length

研究概览

简要总结

The purpose of this study is to better understand the impact of weight-loss surgery on telomere length. Telomeres are a key marker of biological aging of cells. Telomere shortening is a natural process of aging. Several pathologies and lifestyles are associated with premature telomere shortening, such as obesity, diabetes mellitus or sedentary lifestyle. New evidence supports that telomere shortening can be partially reversed by lifestyle changes such as healthy diet, reduced stress, or increased physical activity.

详细描述

This study aims to evaluate the impact of metabolic and bariatric surgery on telomere length as well as the role of type 2 diabetes resolution and oxidative stress improvement on telomere lengthening.

The investigators hypothesize that metabolic and bariatric surgery is associated with the lengthening of telomeres as a possible underlying mechanism of cancer risk reduction.

It is a prospective, single-center study including patients with obesity class II or more (Body Mass Index ≥ 35kg/m2) and patients having had metabolic and bariatric surgery more than 12 months ago.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI ≥ 35 kg/m2 without previous bariatric surgery (control group) OR
  • Having had Sleeve Gastrectomy or Roux-en-Y Gastric Bypass more than 12 months ago and without a weight regain of ≥ 15% of nadir weight (treatment group)

排除标准

  • under 18 years of age
  • no informed consent

结局指标

主要结局

Telomere length

时间窗: 1 day

Difference in terms of telomere length between patients with obesity class II or more (Body Mass Index \[BMI\] ≥ 35kg/m2) and patients after metabolic and bariatric surgery.

次要结局

  • Metabolic disease remission (hypertension and type 2 diabetes remission versus no remission)(1 day)
  • Excessive weight loss (Weight loss [kg] / excess body weight [kg]) x 100 = Percent of excess body weight loss)(1 day)
  • Oxidative stress (Interleukin-1β, Interleukin-6, TNF-α)(1 day)
  • Lifestyle (Simple Lifestyle Indicator Questionnaire)(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Emanuele LoMenzo

Prof.

The Cleveland Clinic

研究点 (1)

Loading locations...

相似试验